Cargando…

Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study

The efficacy and safety of bivalirudin in percutaneous coronary intervention (PCI) has always been a hot topic in perioperative antithrombotic therapy, but there are still some controversies. So studies are needed to provide more evidence, especially the real world study which includes patients excl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yue-cheng, Yao, Wei-jie, Jin, Dong-xia, Zhang, Jing-xia, Wang, Le, Zhang, Rui, Xu, Jing-han, Cong, Hong-liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969278/ https://www.ncbi.nlm.nih.gov/pubmed/33725878 http://dx.doi.org/10.1097/MD.0000000000025003

Ejemplares similares

Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Liu, Xiao-Qiang, et al.
Publicado: (2020)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Glycated hemoglobin level is an independent predictor of major adverse cardiac events after nonfatal acute myocardial infarction in nondiabetic patients: A retrospective observational study
por: Chen, Chin-Lan, et al.
Publicado: (2017)

The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Prognostic factors associated with postoperative adverse outcomes in patients with aortic valve prolapse
por: Ruan, Yanping, et al.
Publicado: (2020)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis
por: Li, Jiabei, et al.
Publicado: (2015)

Elevated preoperative HMGB1 as predictor of myocardial injury post-percutaneous coronary intervention
por: Jin, Peng, et al.
Publicado: (2016)

Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
por: Zhu, Xiang, et al.
Publicado: (2022)

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials
por: Liu, Jiahui, et al.
Publicado: (2021)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
por: Shi, Wenhai, et al.
Publicado: (2019)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Evaluating Diagnostic and Prognostic Value of Plasma miRNA133a in Acute Chest Pain Patients Undergoing Coronary Angiography
por: Ke-Gang, Jia, et al.
Publicado: (2016)

Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Zhang, Hui-Ping, et al.
Publicado: (2016)

Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients
por: Chai, Lina, et al.
Publicado: (2023)

Impact of early postoperative activities on postoperative recovery in patients undergoing abdominal surgery: A protocol for systematic review and meta-analysis
por: Fang, Aohua, et al.
Publicado: (2021)

Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: A community-based study
por: Zhang, Yong, et al.
Publicado: (2018)

Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study
por: Ma, Xiaoteng, et al.
Publicado: (2019)

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Lv, Lina, et al.
Publicado: (2022)

Prognostic value of CHADS(2) and CHA(2)DS(2)-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ma, Xiaoteng, et al.
Publicado: (2020)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study
por: Zhang, Wutang, et al.
Publicado: (2020)

Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Tunçez, Abdullah, et al.
Publicado: (2017)

Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study
por: Wang, Yaochen, et al.
Publicado: (2021)

Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis
por: Gao, Qijun, et al.
Publicado: (2015)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023)

Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk
por: Zhao, Yunfeng, et al.
Publicado: (2021)

Immediate versus deferred stenting for patients undergoing primary or emergent percutaneous coronary intervention: Protocol for a systematic review and meta-analysis
por: Liu, Yong, et al.
Publicado: (2017)

Charlson comorbidity index and 1-year poor outcomes in elderly patients undergoing successful percutaneous coronary intervention: A retrospective study
por: Balun, Ahmet, et al.
Publicado: (2023)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021)

Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients: A Longitudinal Cohort Study
por: Gijsberts, Crystel M., et al.
Publicado: (2015)

Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Effects of recombinant human brain natriuretic peptide in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis
por: Ning, Cheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k8pbu7ire8vv5s15qm2oksk48n